JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 11, 2003; DOI: 10.1124/jpet.103.053553


0022-3565/03/3072-615-625$20.00
JPET 307:615-625, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.053553v1
jpet.103.053553v2
307/2/615    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varbiro, G.
Right arrow Articles by Gallyas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varbiro, G.
Right arrow Articles by Gallyas, F., Jr.

CARDIOVASCULAR

Protective Effect of Amiodarone but Not N- Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition

Gabor Varbiro, Ambrus Toth, Antal Tapodi, Zita Bognar, Balazs Veres, Balazs Sumegi, and Ferenc Gallyas, Jr.

Institute of Biochemistry and Medical Chemistry (G.V., A.T., Z.B., B.V., B.S.), Department of Cardiology (A.T.), Medical School, University of Pecs, Pecs, Hungary; Hungarian Academy of Sciences (B.S.), Research Group for Mitochondrial Function and Mitochondrial Diseases, Budapest, Hungary; and Department of Anatomy (F.G.), School of Medical Sciences, University of Bristol, Bristol, United Kingdom

Amiodarone is a widely used and potent antiarrhythmic agent that is metabolized to desethylamiodarone. Both amiodarone and its metabolite possess antiarrhythmic effect, and both compounds can contribute to toxic side effects. Here, we compare the effect of amiodarone and desethylamiodarone on mitochondrial energy metabolism, membrane potential, and permeability transition and on mitochondria-related apoptotic events. Amiodarone but not desethylamiodarone protects the mitochondrial energy metabolism of the perfused heart during ischemia in perfused hearts. At low concentrations, amiodarone stimulated state 4 respiration due to an uncoupling effect, inhibited the Ca2+-induced mitochondrial swelling, whereas it dissipated the mitochondrial membrane potential ({Delta}{psi}), and prevented the ischemia-reperfusion-induced release of apoptosis-inducing factor (AIF). At higher concentrations, amiodarone inhibited the mitochondrial respiration and simulated a cyclosporin A (CsA)-independent mitochondrial swelling. In contrast to these, desethylamiodarone did not stimulate state 4 respiration, did not inhibit the Ca2+-induced mitochondrial permeability transition, did not induce the collapse of {Delta}{psi} in low concentrations, and did not prevent the nuclear translocation of AIF in perfused rat hearts, but it induced a CsA-independent mitochondrial swelling at higher concentration, like amiodarone. That is, desethylamiodarone lacks the protective effect of amiodarone seen at low concentrations, such as the inhibition of calcium-induced mitochondrial permeability transition and inhibition of the nuclear translocation of the proapoptotic AIF. On the other hand, both amiodarone and desethylamiodarone at higher concentration induced a CsA-independent mitochondrial swelling, resulting in apoptotic death that explains their extracardiac toxic effect.


Received for publication April 28, 2003
Accepted August 4, 2003.

Address correspondence to: Dr. Balazs Sumegi, Institute of Biochemistry and Medical Chemistry, Medical School, University of Pecs, 12 Szigeti St., H-7624 Pecs, Hungary. E-mail: balazs.sumegi{at}aok.pte.hu




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. Sanoudou, E. Vafiadaki, D. A. Arvanitis, E. Kranias, and A. Kontrogianni-Konstantopoulos
Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies
Physiol Genomics, April 14, 2005; 21(2): 131 - 143.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Chen, Z. Zsengeller, C.-Y. Xiao, and C. Szabo
Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1
Cardiovasc Res, September 1, 2004; 63(4): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-Y. Xiao, M. Chen, Z. Zsengeller, and C. Szabo
Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 498 - 504.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.